Defunct Company
Total Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
1,610
NCT00365326
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
Phase: Phase 1
Role: Collaborator
Start: Jan 31, 2006
Completion: Jun 30, 2008
NCT01386216
Safety Study of Bone Marrow Cell Concentrate Prepared Using the Magellan System to Treat Critical Limb Ischemia (CLI)
Role: Lead Sponsor
Start: Apr 30, 2011
Completion: Dec 31, 2016
NCT01837264
Phase I, Arteriocyte Magellan MAR01 Therapy - Compartment Syndrome and Battlefield Trauma
Start: Jan 31, 2013
Completion: Jan 31, 2017
NCT01843686
Using Autologous Platelet Rich Plasma (PRP) Gel to Treat Deep 2nd and 3rd Degree Burns
Start: Apr 30, 2013
Completion: Mar 31, 2018
NCT02071979
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Phase: N/A
Start: Apr 30, 2014
Completion: Not specified
NCT02169362
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
Start: Jul 31, 2014
Completion: May 31, 2018